Assessment of psychological symptom burden using the Hospital Anxiety and Depression Scale in different allergic disease groups

Selma Yeşilkaya

doi:10.38053/acmj.1860417

Assessment of psychological symptom burden using the Hospital Anxiety and Depression Scale in different allergic disease groups

Abstract

Aims: The aim of this study is to evaluate the prevalence of anxiety and depression in patients attending the Immunology and Allergy outpatient clinic using the Hospital Anxiety and Depression Scale (HADS) and to examine the differences between different disease groups. Methods: This descriptive cross-sectional study was conducted in December 2025 at the Immunology and Allergy Outpatient Clinic of Samsun Training and Research Hospital. A total of 215 patients aged 18 years and older were included in the study. The patients' demographic characteristics were recorded, and the HADS was administered. For both subscales, scores of 0-7 were considered normal, 8-10 were considered borderline, and 11-21 were considered abnormal. Results: 61.40% of patients were female, with a median age of 42 (27-56) years. The most common diagnoses were allergic rhinitis (29.77%), chronic urticaria (28.84%), and asthma (19.53%). 24.65% of patients showed borderline anxiety, 25.12% showed abnormal anxiety; 17.21% showed borderline depression, and 13.95% showed abnormal depression. The depression score was significantly higher in the chronic urticaria group compared to the allergic rhinitis group (p=0.023). No difference was found between the diagnosis groups in terms of anxiety scores (p=0.369). The anxiety rate was significantly higher in females than in males (p<0.001). Conclusion: Symptoms of anxiety and depression are frequently observed in allergic diseases. The high rate of depression, particularly in patients with chronic urticaria, suggests that clinicians should be vigilant for psychological distress in this patient group.

Keywords

References

GBD 2021 Asthma and Allergic Diseases Collaborators. Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the global burden of disease study 2021. Lancet Respir Med. 2025;13(5):425-446. doi:10.1016/S2213-2600(25)00003-7
Baiardini I, Braido F, Brandi S, Canonica GW. Allergic diseases and their impact on quality of life. Ann Allergy Asthma Immunol. 2006;97(4):419-476. doi:10.1016/S1081-1206(10)60928-3
Agache I, Torres M, Eguiluz-Gracia I, et al. Economic impact of allergic diseases and asthma-the HEAD pan-european registry. Allergy. 2025; 80(6):1677-1701. doi:10.1111/all.16596
Xu X, Li S, Chen Y, et al. Association between allergic diseases and mental health conditions: an umbrella review. J Allergy Clin Immunol. 2025;155(3):701-713. doi:10.1016/j.jaci.2024.10.030
Conway AE, Verdi M, Kartha N, et al. Allergic diseases and mental health. J Allergy Clin Immunol Pract. 2024;12(9):2298-2309. doi:10.1016/ j.jaip.2024.05.049
Chida Y, Hamer M, Steptoe A. A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and meta-analysis. Psychosom Med. 2008;70(1):102-116. doi:10.1097/PSY. 0b013e31815c1b71
Jarosz M, Syed S, Błachut M, Badura Brzoza K. Emotional distress and quality of life in allergic diseases. Wiad Lek. 2020;73(2):370-373.
González-Díaz SN, Arias-Cruz A, Elizondo-Villarreal B, Monge-Ortega OP. Psychoneuroimmunoendocrinology: clinical implications. World Allergy Organ J. 2017;10(1):19. doi:10.1186/s40413-017-0151-6

Huang Y, Xiao Y, Zhang X, Li J, Chen X, Shen M. A meta-analysis of observational studies on the association of chronic urticaria with symptoms of depression and anxiety. Front Med (Lausanne). 2020;7:39. doi:10.3389/fmed.2020.00039
Di Marco F, Verga M, Santus P, et al. Close correlation between anxiety, depression, and asthma control. Respir Med. 2010;104(1):22-28. doi:10. 1016/j.rmed.2009.08.005
Muñoz-Cano R, Ribó P, Araujo G, Giralt E, Sanchez-Lopez J, Valero A. Severity of allergic rhinitis impacts sleep and anxiety: results from a large Spanish cohort. Clin Transl Allergy. 2018;8:23. doi:10.1186/s13601-018-0212-0
Rodrigues J, Franco-Pego F, Sousa-Pinto B, Bousquet J, Raemdonck K, Vaz R. Anxiety and depression risk in patients with allergic rhinitis: a systematic review and meta-analysis. Rhinology. 2021;59(4):360-373. doi:10.4193/Rhin21.087
Bawany F, Northcott CA, Beck LA, Pigeon WR. Sleep disturbances and atopic dermatitis: relationships, methods for assessment, and therapies. J Allergy Clin Immunol Pract. 2021;9(4):1488-1500. doi:10.1016/j.jaip. 2020.12.007
Minhas S, Chandan JS, Knibb R, Diwakar L, Adderley N. Association between atopic disorders and mental ill health: a UK-based retrospective cohort study. BMJ Open. 2025;15(5):e089181. doi:10.1136/bmjopen- 2024-089181
Tat TS. Higher levels of depression and anxiety in patients with chronic urticaria. Med Sci Monit. 2019;25:115-120. doi:10.12659/MSM.912362
Bavbek S, Kumbasar H, Tuğcu H, Misirligil Z. Psychological status of patients with seasonal and perennial allergic rhinitis. J Investig Allergol Clin Immunol. 2002;12(3):204-210.
Tas HI, Caglar O. The role of anxious temperament in patients with allergic rhinitis. Saudi Med J. 2019;40(1):45-51. doi:10.15537/smj.2019.1.23754
Kurukulaaratchy RJ, Freeman A, Bansal AT, et al. Evaluation of the effect of multimorbidity on difficult-to-treat asthma using a novel score (MiDAS): a multinational study of asthma cohorts. Lancet Respir Med. 2025;13(9):821-832. doi:10.1016/S2213-2600(25)00135-3
Porsbjerg C, Melén E, Lehtimäki L, Shaw D. Asthma. Lancet. 2023; 401(10379):858-873. doi:10.1016/S0140-6736(22)02125-0
Oland AA, Booster GD, Bender BG. Integrated behavioral health care for management of stress in allergic diseases. Ann Allergy Asthma Immunol. 2018;121(1):31-36. doi:10.1016/j.anai.2018.05.002
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370. doi:10.1111/j.1600-0447.1983.tb09716.x
Aydemir O, Hastane anksiyete ve depresyon olcegi Turkce formunun gecerlilik ve guvenilirligi. Turk Psikiyatri Derg. 1997;(8):187-280.
Safia A, Elhadi UA, Karam M, Merchavy S, Khater A. A meta-analysis of the prevalence and risk of mental health problems in allergic rhinitis patients. J Psychosom Res. 2024;184:111813. doi:10.1016/j.jpsychores. 2024.111813
Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1:29. doi:10.1186/1477-7525-1-29
Huang Y, Xiao Y, Zhang X, Li J, Chen X, Shen M. A meta-analysis of observational studies on the association of chronic urticaria with symptoms of depression and anxiety. Front Med (Lausanne). 2020;7:39. doi:10.3389/fmed.2020.00039
Shariat M, Pourpak Z, Sabetkish N, Khalesi M, Sharifi L, Moin M. Evaluation of psychological score and quality of life in adults with allergic rhinitis and assessment of related risk factors. Tanaffos. 2017; 16(3):233-239.
Stanescu S, Kirby SE, Thomas M, Yardley L, Ainsworth B. A systematic review of psychological, physical health factors, and quality of life in adult asthma. NPJ Prim Care Respir Med. 2019;29(1):37. doi:10.1038/s41533-019-0149-3
Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers. 2018;4(1):1. doi:10.1038/s41572-018-0001-z
LeBovidge JS, Schneider LC. Depression and anxiety in patients with atopic dermatitis: recognizing and addressing mental health burden. Ann Allergy Asthma Immunol. 2025;134(5):506-515. doi:10.1016/j.anai. 2025.02.017
Konstantinou GN, Konstantinou GN. Psychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis. Clin Transl Allergy. 2019;9:42. doi:10.1186/s13601-019-0278-3
Huang Y, Xiao Y, Jing D, et al. Association of chronic spontaneous urticaria with anxiety and depression in adolescents: a mediation analysis. Front Psychiatry. 2021;12:655802. doi:10.3389/fpsyt.2021.655802
Sánchez-Díaz M, Rodríguez-Pozo JÁ, Latorre-Fuentes JM, Salazar-Nievas MC, Alejandro ML, Arias-Santiago S. Sleep quality as a predictor of quality-of-life and emotional status impairment in patients with chronic spontaneous urticaria: a cross-sectional study. Int J Environ Res Public Health. 2023;20(4):3508. doi:10.3390/ijerph20043508
Jerković H, Bešlić I, Ćesić D, Šitum M. The psychosocial burden of urticaria. Rad Hrvatske akademije znanosti i umjetnosti. Medicinske Znanosti. 2021;548(56-57):98-103. doi:10.21857/9xn31cogdy
Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77 (3):734-766. doi:10.1111/all.15090
Zuberbier T, Ensina LF, Giménez-Arnau A, et al. Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment. Lancet. 2024;404(10450):393-404. doi:10.1016/S0140-6736 (24)00852-3
Ghazanfar MN, Sørensen JA, Zhang D, Holgersen NK, Vestergaard C, Thomsen SF. Occurrence and risk factors of mental disorders in patients with chronic urticaria. World Allergy Organ J. 2023;16(11):100835. doi: 10.1016/j.waojou.2023.100835
Konstantinou GN, Podder I, Konstantinou G. Mental health interventions in refractory chronic spontaneous urticaria: a call to expand treatment guidelines. Cureus. 2025;17(3):e81443. doi:10.7759/cureus.81443
Steel Z, Marnane C, Iranpour C, et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. Int J Epidemiol. 2014;43(2):476-493. doi:10.1093/ije/dyu038
Altemus M, Sarvaiya N, Neill Epperson C. Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol. 2014;35(3):320-330. doi:10.1016/j.yfrne.2014.05.004
Pesce L, van Veen T, Carlier I, et al. Gender differences in outpatients with anxiety disorders: the leiden routine outcome monitoring study. Epidemiol Psychiatr Sci. 2016;25(3):278-287. doi:10.1017/S204579601500 0414
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52(2):69-77. doi:10.1016/s0022-3999(01)00296-3
DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160 (14):2101-2107. doi:10.1001/archinte.160.14.2101
Herrmann C. International experiences with the hospital anxiety and depression scale--a review of validation data and clinical results. J Psychosom Res. 1997;42(1):17-41. doi:10.1016/s0022-3999(96)00216-4

Details

Primary Language

English

Subjects

Allergy

Journal Section

Research Article

Authors

Selma Yeşilkaya ^*
0000-0002-1841-0177
Türkiye

Publication Date

March 10, 2026

Submission Date

January 10, 2026

Acceptance Date

February 20, 2026

Published in Issue

Year 2026 Volume: 8 Number: 2

DOI

https://doi.org/10.38053/acmj.1860417

IZ

https://izlik.org/JA62GU29KP

Cite

RIS / Bibtex

APA

Yeşilkaya, S. (2026). Assessment of psychological symptom burden using the Hospital Anxiety and Depression Scale in different allergic disease groups. Anatolian Current Medical Journal, 8(2), 311-318. https://doi.org/10.38053/acmj.1860417

AMA

1.Yeşilkaya S. Assessment of psychological symptom burden using the Hospital Anxiety and Depression Scale in different allergic disease groups. Anatolian Curr Med J / ACMJ / acmj. 2026;8(2):311-318. doi:10.38053/acmj.1860417

Chicago

Yeşilkaya, Selma. 2026. “Assessment of Psychological Symptom Burden Using the Hospital Anxiety and Depression Scale in Different Allergic Disease Groups”. Anatolian Current Medical Journal 8 (2): 311-18. https://doi.org/10.38053/acmj.1860417.

EndNote

Yeşilkaya S (March 1, 2026) Assessment of psychological symptom burden using the Hospital Anxiety and Depression Scale in different allergic disease groups. Anatolian Current Medical Journal 8 2 311–318.

IEEE

[1]S. Yeşilkaya, “Assessment of psychological symptom burden using the Hospital Anxiety and Depression Scale in different allergic disease groups”, Anatolian Curr Med J / ACMJ / acmj, vol. 8, no. 2, pp. 311–318, Mar. 2026, doi: 10.38053/acmj.1860417.

ISNAD

Yeşilkaya, Selma. “Assessment of Psychological Symptom Burden Using the Hospital Anxiety and Depression Scale in Different Allergic Disease Groups”. Anatolian Current Medical Journal 8/2 (March 1, 2026): 311-318. https://doi.org/10.38053/acmj.1860417.

JAMA

1.Yeşilkaya S. Assessment of psychological symptom burden using the Hospital Anxiety and Depression Scale in different allergic disease groups. Anatolian Curr Med J / ACMJ / acmj. 2026;8:311–318.

MLA

Yeşilkaya, Selma. “Assessment of Psychological Symptom Burden Using the Hospital Anxiety and Depression Scale in Different Allergic Disease Groups”. Anatolian Current Medical Journal, vol. 8, no. 2, Mar. 2026, pp. 311-8, doi:10.38053/acmj.1860417.

Vancouver

1.Selma Yeşilkaya. Assessment of psychological symptom burden using the Hospital Anxiety and Depression Scale in different allergic disease groups. Anatolian Curr Med J / ACMJ / acmj. 2026 Mar. 1;8(2):311-8. doi:10.38053/acmj.1860417